Sarepta Announces that Screening and Enrollment are Underway in ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne
– Approximately 25 non-ambulatory participants will receive sirolimus as part of the regimen in Cohort 8 of the ENDEAVOR study – The enhanced immunosuppressive... Read more.
Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership
Partnership marks the first introduction of Shield™ multi-cancer detection test in the region with availability across Hong Kong, Singapore and the Philippines... Read more.
Ameresco Completes District-Wide Energy Efficiency Transformation for Charlo School District
The two-phased Energy Performance Contract supports long-term cost savings, facility performance, and enhanced learning environments for the Montana school district... Read more.
HyperLight Demonstrates Low-Power 1.6T-DR8 TFLN-based Reference Transceiver Assembled by TFC
CAMBRIDGE, Mass.–(BUSINESS WIRE)–#AIinfrastructure–HyperLight Corporation (“HyperLight”) today announced a major milestone in low-power optical... Read more.
Semtech Launches 224Gbps IC Family for Linear Optics Era
Purpose-built TIAs and drivers address LPO through NPO at 800G, 1.6T and higher densities as AI data centers move beyond DSP-based architectures CAMARILLO, Calif.–(BUSINESS... Read more.
Okta Announces New Blueprint for the Secure Agentic Enterprise
New framework helps enterprises answer defining questions to secure the agentic era Customers can leverage Okta for AI Agents, generally available (GA) April 30,... Read more.
Ferguson Files Definitive Proxy Materials and Transition Report
NEWPORT NEWS, Va.–(BUSINESS WIRE)–On March 16, 2026, Ferguson Enterprises Inc. (the “Company”) filed a Definitive Proxy Statement, Definitive... Read more.
Crescita Announces Definitive Agreement to Be Acquired by ClinActiv Holdings in an All-Cash Transaction at a Significant Premium
LAVAL, Quebec–(BUSINESS WIRE)–Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”) today announced that it has... Read more.
Flowserve Appoints Brian Savoy to Board of Directors
DALLAS–(BUSINESS WIRE)–Flowserve Corporation (NYSE:FLS), a leading provider of flow control products and services for the global infrastructure markets,... Read more.
Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized
Early access programs expand globally: 200+ physician inquiries across 30+ countries; $4.2M in initial program revenue recognized CRC leads BOT+BAL clinical development:... Read more.